STAT+: What’s in Congress’ sweeping health care deal: PBM reform, telehealth, science funding

Congressional appropriations committees offered a near-total rebuke of President Trump’s proposed downsizing and reshaping of the NIH.

The principal deputy director of the CDC said he would not view the loss of the United States' measles elimination status as a significant event.

After I was diagnosed with low-risk prostate cancer, I came very close to undergoing surgery I didn't need.

GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.

Stem cell IVF could enable same-sex couples and single parents to have genetically related children. It’s time to think through ethics and regulation.

These could arguably be the largest changes ever to cell and gene therapy oversight in the U.S.

Experts worry that health officials' use of 'shared decision-making' in new vaccine guidance distorts the concept's meaning and disregards the importance of evidence.